GGrantIndex
← Leaderboards

Sudarshan K Rajagopal

Duke University

$6,060,418
Attributed
$8,109,967
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY201325
$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,109,967 · 5

By mechanism

R01$7,344,427 · 3
K08$606,540 · 1
R03$159,000 · 1

Top collaborators

Most similar at Duke University

Same institution · by research overlap

Others in their field

Top investigators on “Signal Transduction

Research focus

Signal TransductionResponseLigandsReceptorPhosphorylationHeterotrimeric Gtp-Binding ProteinsAgonistDrug TargetingGtp-Binding ProteinsUnited States National Institutes Of HealthPlayMediatingAdaptor Signaling ProteinBeta-ArrestinPatternCell PhysiologyDrug DevelopmentInflammationKnock-DownG-Protein-Coupled ReceptorsBiologicalCxcr3 GeneFda ApprovedChemokine

Grant awards (28)

A Novel high resolution MS platform for high-throughput screening of G protein-coupled receptors$480,681
R01 · FY2025 · GM
Biasing CXCR3 Signaling to Modulate the Inflammatory Response$357,171
R01 · FY2025 · GM · contact PI
Xenon MRI in Pulmonary Hypertension$736,853
R01 · FY2024 · HL · contact PI
Biasing CXCR3 Signaling to Modulate the Inflammatory Response$357,171
R01 · FY2024 · GM · contact PI
A Novel high resolution MS platform for high-throughput screening of G protein-coupled receptors$340,162
R01 · FY2024 · GM
Biasing CXCR3 Signaling to Modulate the Inflammatory Response$76,475
R01 · FY2024 · GM · contact PI
Xenon MRI in Pulmonary Hypertension$763,634
R01 · FY2023 · HL · contact PI
Biasing CXCR3 Signaling to Modulate the Inflammatory Response$357,171
R01 · FY2023 · GM · contact PI
A Novel high resolution MS platform for high-throughput screening of G protein-coupled receptors$342,308
R01 · FY2023 · GM
Biasing CXCR3 Signaling to Modulate the Inflammatory Response$83,982
R01 · FY2023 · GM · contact PI
Biasing CXCR3 Signaling to Modulate the Inflammatory Response$41,992
R01 · FY2023 · GM · contact PI
Biasing CXCR3 Signaling to Modulate the Inflammatory Response$12,397
R01 · FY2023 · GM · contact PI
Xenon MRI in Pulmonary Hypertension$769,506
R01 · FY2022 · HL · contact PI
Biasing CXCR3 Signaling to Modulate the Inflammatory Response$357,171
R01 · FY2022 · GM · contact PI
Xenon MRI in Pulmonary Hypertension$665,954
R01 · FY2021 · HL · contact PI
Biasing CXCR3 Signaling to Modulate the Inflammatory Response$312,783
R01 · FY2021 · GM · contact PI
Biasing CXCR3 Signaling to Modulate the Inflammatory Response$312,783
R01 · FY2020 · GM · contact PI
Biasing CXCR3 Signaling to Modulate the Inflammatory Response$43,713
R01 · FY2020 · GM · contact PI
Biasing CXCR3 Signaling to Modulate the Inflammatory Response$312,783
R01 · FY2019 · GM · contact PI
Biasing CXCR3 Signaling to Modulate the Inflammatory Response$310,840
R01 · FY2018 · GM · contact PI
Beta-Arrestin Regulation of VEGFR3 Signaling in Pulmonary Hypertension$79,500
R03 · FY2018 · HL · contact PI
Biasing CXCR3 Signaling to Modulate the Inflammatory Response$308,897
R01 · FY2017 · GM · contact PI
Noncanonical Receptor Signaling in Pulmonary Arterial Hypertension$150,691
K08 · FY2017 · HL · contact PI
Beta-Arrestin Regulation of VEGFR3 Signaling in Pulmonary Hypertension$79,500
R03 · FY2017 · HL · contact PI
Noncanonical Receptor Signaling in Pulmonary Arterial Hypertension$148,097
K08 · FY2016 · HL · contact PI
Noncanonical Receptor Signaling in Pulmonary Arterial Hypertension$102,584
K08 · FY2015 · HL · contact PI
Noncanonical Receptor Signaling in Pulmonary Arterial Hypertension$102,584
K08 · FY2014 · HL · contact PI
Noncanonical Receptor Signaling in Pulmonary Arterial Hypertension$102,584
K08 · FY2013 · HL · contact PI